# FDA Inspection 1204063 - Slawomir Jeka, M.D., Ph.D. - March 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/slawomir-jeka-md-phd/a9c3b96e-9b0d-4a9f-9662-2dbd7d754c2b
Source feed: FDA_Inspections

> FDA Inspection 1204063 for Slawomir Jeka, M.D., Ph.D. on March 24, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204063
- Company Name: Slawomir Jeka, M.D., Ph.D.
- Inspection Date: 2023-03-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 919188 - 2015-01-29](https://www.keypedia.com/records/fda_inspections/slawomir-jeka-md-phd/adb40e21-d09a-4b1c-909d-9a80544698d5)

Company: https://www.keypedia.com/companies/slawomir-jeka-md-phd/b8609605-8264-4955-b57e-772c8ae07c07

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c